SEARCH

SEARCH BY CITATION

Disclaimer: Supplementary materials have been peer-reviewed but not copyedited.

FilenameFormatSizeDescription
ajt12137-sup-0001-FigureS1.tif906KFigure S1: The Syk inhibitor R406 induces apoptosis in EBV+ SLCL.
ajt12137-sup-0002-FigureS2.tif1027KFigure S2: Effect of the R406 prodrug fostamatinib on in vivo tumor growth from individual mice.
ajt12137-sup-0003-FigureS3.tif984KFigure S3: Effects of the PI3K/Akt inhibitor LY294002 on tumor growth when administered prior to formation of palpable tumor.
ajt12137-sup-0004-FigureS4.tif1039KFigure S4: Effects of the PI3K/Akt inhibitor LY294002 on tumor growth when administered after the formation of palpable tumor.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.